ArticleOrthopaedic journal of sports medicine2026
Arthroscopic Microfracture for Focal Glenoid Osteochondral Lesions in Young Active-Duty Military Patients: A Minimum 10-Year Follow-Up.
Article in Orthopaedic journal of sports medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Glenoid osteochondral defects (OCDs), while uncommon, are a recognized source of shoulder pain and dysfunction, particularly in young, active individuals. Arthroscopic microfracture (MFx) is a commonly used surgical option. However, long-term outcomes remain poorly defined. Purpose: To evaluate long-term clinical and functional outcomes after arthroscopic MFx for focal glenoid OCD in active-duty military patients. Study Design: Case series; Level of evidence, 4. Methods: A retrospective review was conducted of 31 active-duty military patients (<54 years) who underwent arthroscopic MFx for focal, full-thickness (Outerbridge grade 4) glenoid OCD with concomitant biceps tendinitis, subacromial bursitis, and partial rotator cuff (RC) tears, performed by a single surgeon between January 2010 and June 2015. Descriptive data, trauma history, time from symptom onset to surgical intervention, and magnetic resonance imaging (MRI) findings were recorded. Pre- and postoperative clinical assessments included shoulder range of motion (ROM), visual analog scale (VAS) for pain, Single Assessment Numeric Evaluation (SANE), and American Shoulder and Elbow Surgeons (ASES) scores. Since minimal clinically important differences for glenoid MFx are not defined, validated thresholds from shoulder arthroplasty literature were used for context. Rates of return to sports, military duty, and revision procedures were assessed at final follow-up. Results: The mean follow-up was 138 ±14.85 months (range, 120-182 months). The mean age was 36 years (range, 22-54 months), and 94% (29/31) were men. A history of traumatic injury was recorded in 61% (19/31) of patients. The mean time from symptom onset to surgery was 31 ± 46.6 months. No significant differences in ROM were found postoperatively ( Conclusion: Arthroscopic MFx offers durable pain relief and functional improvement for focal glenoid OCD with concomitant biceps tendinitis, subacromial bursitis, or partial RC tears in high-demand military patients. At a minimum 10-year follow-up, outcomes demonstrated sustained clinical benefits, high return to duty, moderate return to sports (RTS), and low revision rates. Limited MRI sensitivity and prolonged time to surgical treatment highlight the importance of early clinical suspicion and timely surgical intervention in this challenging population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.